Edition:
United Kingdom

KemPharm Inc (KMPH.OQ)

KMPH.OQ on NASDAQ Stock Exchange Global Market

2.32USD
14 Dec 2018
Change (% chg)

$-0.19 (-7.57%)
Prev Close
$2.51
Open
$2.49
Day's High
$2.49
Day's Low
$2.31
Volume
8,842
Avg. Vol
44,566
52-wk High
$8.35
52-wk Low
$2.01

Chart for

About

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company's product candidate, KP201/APAP, consists of KP201, its prodrug of hydrocodone, which is... (more)

Overall

Beta: --
Market Cap(Mil.): $55.33
Shares Outstanding(Mil.): 14.66
Dividend: --
Yield (%): --

Financials

  KMPH.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -3.15 -- --
ROI: -57.85 9.01 14.96
ROE: -- 10.15 16.52

Earnings vs. Estimates